Related Experiment Videos
Immunohistological approaches to human prostatic epithelial cells
The Prostate
|January 1, 1980
Summary
Researchers developed specific antibodies to distinguish between prostatic acid phosphatase (PAP) and lysosomal acid phosphatase (L-AcP). This distinction aids in identifying metastatic prostate cancer cells in biopsies.
Area of Science:
- Biochemistry
- Immunology
- Cell Biology
Background:
- Acid phosphatases, specifically prostatic acid phosphatase (PAP) and lysosomal acid phosphatase (L-AcP), play distinct roles in cellular functions.
- Understanding the distribution and antigenic differences of these enzymes is crucial for diagnostic applications.
Purpose of the Study:
- To develop specific antisera against PAP and L-AcP.
- To investigate the tissue distribution of PAP and L-AcP using immunofluorescence techniques.
- To evaluate the feasibility of using anti-PAP antibodies for identifying metastatic prostate cancer.
Main Methods:
- Purification of prostatic acid phosphatase (PAP) and lysosomal acid phosphatase (L-AcP) to serve as antigens.
- Preparation of specific antisera against PAP and L-AcP.
- Indirect immunofluorescence and unlabeled antibody methods for enzyme localization in various cell types and tissues.
Main Results:
- Established distinct antigenic profiles for PAP and L-AcP.
- L-AcP was detected in epithelial cells, fibroblasts, and peripheral blood cells (excluding erythrocytes), localized in perinuclear granules.
- PAP was exclusively found in prostatic epithelial cells.
- A significant decrease in PAP biosynthesis was observed in long-term cultures of prostatic epithelial cells.
Conclusions:
- The antigenic difference between PAP and L-AcP allows for their specific identification.
- The high concentration of PAP in prostatic epithelial cells, coupled with its specific localization, makes anti-PAP immunofluorescence a viable method for detecting metastatic prostate carcinoma in biopsy samples.